TY - JOUR
TI - Molecular classification guides for the postoperative adjuvant therapy of early-stage endometrial carcinoma
AU - Peng Yixin
AU - Yang Xingsheng
JN - Thermal Science
PY - 2024
VL - 28
IS - 3
SP - 2217
EP - 2224
PT - Article
AB - Surgical treatment has been widely used for early-stage endometrial carcinoma  patients, but 15-20% of patients had a poor prognosis, requiring a  postoperative adjuvant therapy. With the development of molecular  classification of endometrial carcinoma, the combination of molecular and  clinicopathological factors can guide the prognosis risk assessment and make  the adjuvant therapy selection more accurate, as a result, the survival  outcome of patients can be greatly improved. In this article, the molecular  classification of endometrial carcinoma is reviewed, and its guidance to the  postoperative adjuvant therapy for early-stage endometrial carcinoma is  discussed. It concludes that the molecular classification opens up the  opportunity of creating new ideas for adjuvant treatment strategies for  early endometrial cancer.